The Space Manufacturing Race

Varda Space: Biomanufacturing in Microgravity and Hypersonic Testing

Key Concepts:

• Biologics formulation in microgravity
• Full-stack aerospace manufacturing
• Hypersonic reentry and testing
• Cadence of flights
• Pharmaceutical supply chain integration
• Reusable launch infrastructure (SpaceX Falcon 9)
• Defense applications (hypersonic wind tunnel)

Biologics Manufacturing in Space

Varda Space aims to leverage microgravity to create novel drug formulations impossible to produce on Earth. The company is building a biologics lab to prepare these formulations for flight.

• Purpose: Microgravity allows for the creation of unique drug formulations.
• Funding: Series funding is being used to build out a large lab space to vet drug formulations before spaceflight and create a pipeline.
• Process: Drugs are manufactured in orbit under microgravity conditions, resulting in different properties compared to Earth-made drugs. These drugs are then brought back to Earth.

Full-Stack Manufacturing and Cadence

Varda has transitioned to in-house manufacturing to control its supply chain and increase the cadence of flights.

• Rationale: Moving away from third-party manufacturing (Rocket Lab) allows for greater control and scalability.
• Scaling: The goal is to fly four times next year and then double the flight cadence every year thereafter.
• Capabilities: Owning more of the manufacturing process expands the capabilities of the spacecraft for biopharmaceutical production.

Hypersonic Reentry and Defense Applications

Varda's reentry process, involving speeds of Mach 25, is of interest to the Department of Defense (DOD) for hypersonic testing.

• Reentry: The spacecraft reenters the atmosphere at 25 times the speed of sound, creating a plasma effect.
• DOD Interest: The DOD is interested in studying flight dynamics at Mach 25, a regime difficult to replicate on the ground.
• Hypersonic Wind Tunnel: Varda's spacecraft acts as a hypersonic wind tunnel, allowing the DOD to test new materials, wing shapes, and sensors.
• Benefits: Faster, more frequent, and cheaper testing compared to traditional methods.
• National Security: Enables the US to catch up to and surpass near-peer adversaries like China and Russia in hypersonic capabilities.

Talent and Competition

While talent acquisition is a general challenge, Varda faces limited competition in the reentry market due to its unique focus and capabilities.

• Limited Competition: Varda's smaller size, higher cadence, non-human rating, and lower cost differentiate it from competitors like SpaceX's Dragon and Boeing's Starliner.
• Complementary Role: Varda sees itself as complementary to other space companies.
• Scaling Cadence: The primary challenge is scaling up the flight cadence to integrate into the pharmaceutical supply chain.

Pharmaceutical Integration

The ultimate goal is to become a reliable supplier of novel drug formulations to the pharmaceutical industry.

• Pharmaceutical Focus: The pharmaceutical industry is primarily interested in new drug formulations, not the space aspect itself.
• Zero Gravity Oven: Varda aims to be seen as a "zero gravity oven" for the pharmaceutical industry.
• Integration: Increased flight cadence will facilitate integration into the pharmaceutical supply chain.

Launch Costs and Infrastructure

SpaceX's Falcon 9 and the Transporter program are critical infrastructure enabling Varda's business model.

• Launch Costs: SpaceX launch costs represent 20-25% of Varda's total mission costs.
• Reusable Launch: Falcon 9's reusability is essential for Varda's business model.
• Transporter Program: SpaceX's Transporter missions provide affordable access to orbit.
• Infrastructure Layer: SpaceX provides a fundamental infrastructure layer, similar to mobile and app stores for Uber and Airbnb.
• Long-Term Bookings: Varda has booked SpaceX launches through Q3 2027.

Long-Term Business Model

The long-term business model involves serving both the defense and pharmaceutical industries.

• Unique American Asset: Varda is positioned as a unique American asset due to its reusable and commercial launch capabilities.
• Defense Applications: Continuous service for the DOD as a hypersonic wind tunnel.
• DOD Testing: Testing sensors, heat shield materials, flight computers, and navigation systems.
• Infrastructure Role: Acting as infrastructure for the DOD to advance new technologies faster and cheaper.

Conclusion

Varda Space is pioneering biomanufacturing in microgravity and hypersonic reentry testing. By leveraging reusable launch infrastructure and focusing on both pharmaceutical and defense applications, the company aims to establish a sustainable and impactful business model. The key challenges lie in scaling up the flight cadence and integrating into the pharmaceutical supply chain.